Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CD38 | P28907 | 20/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22947225 | 1.00 | CD38 (1.00) | CD38 | |
| SCHEMBL22933156 | 0.87 | CD38 (0.78) | CD38 | |
| SCHEMBL28722981 | 0.87 | CD38 (0.78) | CD38 | |
| SCHEMBL22936247 | 0.86 | CD38 (1.00) | CD38 | |
| SCHEMBL28722510 | 0.86 | CD38 (1.00) | CD38 | |
| SCHEMBL22933151 | 0.83 | CD38 (0.77) | CD38 | |
| SCHEMBL28722935 | 0.83 | CD38 (0.77) | CD38 | |
| SCHEMBL23329454 | 0.81 | CD38 (0.79) | CD38 | |
| SCHEMBL23329082 | 0.80 | CD38 (1.00) | CD38 | |
| SCHEMBL23329158 | 0.80 | CD38 (1.00) | CD38 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4003980-A1 | HETEROBICYCLIC AMIDES AS INHIBITORS OF CD38 | Ribon Therapeutics Inc. (US) | 2022-06-01 | — | — | EP | claimed |
| CN-114423753-A | Heterobicyclic amides as CD38 inhibitors | 里邦医疗公司 | 2022-04-29 | — | — | CN | claimed |